Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Association of Gene Mutations with Response to Arsenic-Containing Compound Qinghuang Powder (复方青黄散) in Patients with Myelodysplastic Syndromes
  
View Full Text  View/Add Comment  Download reader
KeyWord:myelodysplastic syndromes, arsenic, next-generation sequencing, realgar
Author NameAffiliationE-mail
ZHAO Pan, LIANG Jun-bin, DENG Zhong-yang   
HU Xiao-me Department of Hematology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing (100091), China huxiaomei_2@163.com 
Hits: 893
Download times: 0
Abstract:
      Objective: To investigate the relationship between gene mutations and response to Compound Qinghuang Powder (复方青黄散, CQHP) in patients with myelodysplastic syndrome (MDS). Methods: Forty-three MDS patients after treatment with CQHP for 6 months were genotyped by ultra-deep targeted sequencing and the clinical data of patients were collected and the relationship between them was analyzed. Results: Up to 41.86% of patients harbored genet mutations, in most cases with more than one mutation. The most common mutations were in SF3B1, U2AF1, ASXL1, and DNMT3A. After treatment with CQHP, about 88.00% of patients no longer required blood transfusion, or needed half of prior transfusions. Conlusion: CQHP is an effective treatment for patients with MDS, especially those with gene mutations in SF3B1, DNMT3A, U2AF1, and/or ASXL1.
Close